US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zura Bio

1.50

+0.10007.14%

Post-market: 1.47-0.0290-1.93%19:51 EDT

Volume:471.12K

Turnover:679.53K

Market Cap:92.81M

PE:-2.09

High:1.52

Open:1.37

Low:1.35

Close:1.40

Loading ...

Overview Company News Filings

Zura Bio Ltd. Files Initial Ownership Statement for Eric J. Hyllengren, Chief Financial Officer

Zura Bio Announces Inducement Awards for New Employees, Including 672,000 Options for CFO Eric Hyllengren

Zura Bio Ltd. Announces Eric Hyllengren as New CFO, Succeeding Verender Badial in July 2025

Zura Bio Ltd. Files Initial Beneficial Ownership Statement for Director Daniel J. Becker

Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for AI Biotechnology LLC

Zura Bio to Present at Jefferies Healthcare Conference

Zura Bio Holds Annual General Meeting of Shareholders

Zura Bio Ltd. Conducted Annual General Meeting of Shareholders

Zura Bio’s Strategic Advancements and Promising Clinical Trials Support Buy Rating

BRIEF-Zura Bio Launches Global Phase 2 Tibushield Study To Evaluate Tibulizumab In Adults With Hidradenitis Suppurativa

Zura Bio Launches TibuSHIELD Phase 2 Study for HS

Zura Bio launches global Phase 2 TibuSHIELD study evaluating tibulizumab

Zura Bio Ltd. Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab for Hidradenitis Suppurativa

H.C. Wainwright Remains a Hold on Zura Bio (ZURA)

Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Zura Bio (ZURA)

Zura Bio Ltd reports results for the quarter ended March 31 - Earnings Summary

Oppenheimer Sticks to Their Buy Rating for Zura Bio (ZURA)

Zura Bio price target lowered to $17 from $19 at Oppenheimer

Zura Bio Q1 EPS $(0.19) Misses $(0.15) Estimate

Zura Bio Ltd expected to post a loss of 15 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZURA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":1.5,"timestamp":1754078400000,"preClose":1.4,"halted":0,"volume":471119,"hourTrading":{"tag":"盘后","latestPrice":1.471,"preClose":1.5,"latestTime":"19:51 EDT","volume":573,"amount":846.43,"timestamp":1754092260637},"delay":0,"floatShares":24675037,"shares":61874998,"eps":-0.717206,"marketStatus":"Market Closed","change":0.1,"latestTime":"08-01 16:00:00 EDT","open":1.37,"high":1.515,"low":1.345,"amount":679529.2311632,"amplitude":0.121429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.717206,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.4,"latestTime":"09:25 EDT","volume":410,"amount":564.1199839999999,"timestamp":1754054713260},"postHourTrading":{"tag":"盘后","latestPrice":1.471,"preClose":1.5,"latestTime":"19:51 EDT","volume":573,"amount":846.43,"timestamp":1754092260637},"volumeRatio":1.4147746431695074,"impliedVol":1.5783,"impliedVolPercentile":0.5455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","floatShares":24675037,"roa":"-31.40%","roe":"-55.05%","lyrEps":-0.604576,"volumeRatio":1.4147746431695074,"shares":61874998,"dividePrice":0,"high":1.515,"amplitude":0.121429,"preClose":1.4,"low":1.345,"week52Low":0.97,"pbRate":"0.67","week52High":5.07,"institutionHeld":0,"latestPrice":1.5,"eps":-0.717206,"divideRate":0,"volume":471119,"delay":0,"ttmEps":-0.717206,"open":1.37,"prevYearClose":2.5,"prevWeekClose":1.64,"prevMonthClose":1.4,"prevQuarterClose":1.05,"fiveDayClose":1.64,"twentyDayClose":1.13,"sixtyDayClose":1.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZURA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552183434","title":"Zura Bio Ltd. Files Initial Ownership Statement for Eric J. Hyllengren, Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2552183434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552183434?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:19","pubTimestamp":1752787159,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd. has filed an initial statement of beneficial ownership. The filing lists Eric J. Hyllengren as the beneficial owner, serving in the role of Chief Financial Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL3yjQFd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2552431717","title":"Zura Bio Announces Inducement Awards for New Employees, Including 672,000 Options for CFO Eric Hyllengren","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431717","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552431717?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:30","pubTimestamp":1752784225,"startTime":"0","endTime":"0","summary":"HENDERSON, Nev.---- Zura Bio Limited  has announced the issuance of inducement awards to seven new employees, including Eric Hyllengren, the newly appointed Chief Financial Officer. On July 15, 2025, the company granted options to purchase up to 890,950 Class A Ordinary Shares, with 672,000 options awarded to Hyllengren. These awards were approved by the Compensation Committee and the Board, granted outside the 2023 Equity Incentive Plan, and are in alignment with Nasdaq Listing Rule 5635. The options will vest incrementally, with one fourth vesting on the vesting commencement date and the remainder vesting in equal quarterly installments, contingent upon continuous service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLc4nD2v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2548725070","title":"Zura Bio Ltd. Announces Eric Hyllengren as New CFO, Succeeding Verender Badial in July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548725070","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548725070?lang=en_us&edition=fundamental","pubTime":"2025-07-01 18:30","pubTimestamp":1751365834,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd. has announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 7, 2025. He will replace Verender Badial, who will remain with the company as a non-executive employee through July 31, 2025, to ensure a smooth transition. Hyllengren brings over 20 years of financial leadership experience in the life sciences and biotechnology sectors, previously serving in roles at Atara Biotherapeutics and Amgen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via Business Wire  on July 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL91c7hc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00BJJMRZ35.SGD","ATRA","IE00B2B36J28.USD","BK4599","IE0002141913.USD","LU0868494617.USD","BK4534","SG9999001440.SGD","LU2089984988.USD","LU1983299246.USD","LU0122379950.USD","LU0289739699.SGD","BK4585","IE00B4R5TH58.HKD","LU1571399168.USD","IE00BJT1NW94.SGD","LU2242652126.USD","BK4566","LU1061106388.HKD","BK4581","LU0109394709.USD","LU0889565916.HKD","LU0058720904.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","AMGN","LU2468319806.SGD","LU1057294990.SGD","BK4588","LU2242646821.SGD","LU1023059063.AUD","IE0009355771.USD","ZURA","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2539218473","title":"Zura Bio Ltd. Files Initial Beneficial Ownership Statement for Director Daniel J. Becker","url":"https://stock-news.laohu8.com/highlight/detail?id=2539218473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539218473?lang=en_us&edition=fundamental","pubTime":"2025-05-30 09:39","pubTimestamp":1748569169,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Daniel J. Becker as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL3Wx1VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2539341409","title":"Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for AI Biotechnology LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2539341409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539341409?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:14","pubTimestamp":1748463291,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd. has filed an initial statement of beneficial ownership, identifying AI Biotechnology LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL2NvTHv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2538635654","title":"Zura Bio to Present at Jefferies Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2538635654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538635654?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:19","pubTimestamp":1748344760,"startTime":"0","endTime":"0","summary":"The latest update is out from Zura Bio ( ($ZURA) ). On May 27, 2025, Zura Bio announced its participation in the Jefferies Global Healthcare Confer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zura-bio-to-present-at-jefferies-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zura-bio-to-present-at-jefferies-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","HCSG","BK4139","BK4137"],"gpt_icon":0},{"id":"2537373581","title":"Zura Bio Holds Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2537373581","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537373581?lang=en_us&edition=fundamental","pubTime":"2025-05-23 21:49","pubTimestamp":1748008173,"startTime":"0","endTime":"0","summary":"Zura Bio ( ($ZURA) ) has issued an announcement. On May 21, 2025, Zura Bio Limited held its Annual General Meeting of Shareholders where all three ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zura-bio-holds-annual-general-meeting-of-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zura-bio-holds-annual-general-meeting-of-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2537134368","title":"Zura Bio Ltd. Conducted Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2537134368","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537134368?lang=en_us&edition=fundamental","pubTime":"2025-05-23 21:20","pubTimestamp":1748006454,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd. held its Annual General Meeting of Shareholders on May 21, 2025. The meeting included the election of nine directors to the Board, which was approved. The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also approved. An adjournment proposal was not put to a vote as the necessary approvals for the other proposals were obtained.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDLc30J1m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2537835731","title":"Zura Bio’s Strategic Advancements and Promising Clinical Trials Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2537835731","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537835731?lang=en_us&edition=fundamental","pubTime":"2025-05-23 16:17","pubTimestamp":1747988238,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on ZURA stock, giving a Buy rating on May 9. Faisal Khurshid’s rating ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/zura-bios-strategic-advancements-and-promising-clinical-trials-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/zura-bios-strategic-advancements-and-promising-clinical-trials-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA"],"gpt_icon":0},{"id":"2536611856","title":"BRIEF-Zura Bio Launches Global Phase 2 Tibushield Study To Evaluate Tibulizumab In Adults With Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2536611856","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536611856?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:07","pubTimestamp":1747739273,"startTime":"0","endTime":"0","summary":"BRIEF-Zura Bio Launches Global Phase 2 Tibushield Study To Evaluate Tibulizumab In Adults With Hidradenitis SuppurativaMay 20 (Reuters) - Zura Bio Ltd ZURA.O:ZURA BIO LAUNCHES GLOBAL PHASE 2 TIBUSHIEL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RS0SY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2536619115","title":"Zura Bio Launches TibuSHIELD Phase 2 Study for HS","url":"https://stock-news.laohu8.com/highlight/detail?id=2536619115","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536619115?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:58","pubTimestamp":1747738729,"startTime":"0","endTime":"0","summary":"Zura Bio ( ($ZURA) ) has shared an announcement. On May 20, 2025, Zura Bio announced the launch of TibuSHIELD, a global Phase 2 study to evaluate t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zura-bio-launches-tibushield-phase-2-study-for-hs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zura-bio-launches-tibushield-phase-2-study-for-hs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2536616710","title":"Zura Bio launches global Phase 2 TibuSHIELD study evaluating tibulizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2536616710","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536616710?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:35","pubTimestamp":1747737311,"startTime":"0","endTime":"0","summary":"Zura Bio (ZURA) announced the launch of TibuSHIELD, a global Phase 2 clinical study evaluating tibulizumab in adults with moderate to severe HS. Ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zura-bio-launches-global-phase-2-tibushield-study-evaluating-tibulizumab?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zura-bio-launches-global-phase-2-tibushield-study-evaluating-tibulizumab?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2536616622","title":"Zura Bio Ltd. Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab for Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2536616622","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536616622?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:30","pubTimestamp":1747737033,"startTime":"0","endTime":"0","summary":"Zura Bio Limited, a clinical-stage immunology company, has announced the launch of TibuSHIELD, a global Phase 2 clinical study evaluating tibulizumab in adults with moderate to severe hidradenitis suppurativa . This study is the first to assess the dual inhibition of B-cell activating factor  and interleukin-17A  pathways in this patient population. The 28-week study will include a 16-week primary efficacy assessment and a 12-week safety follow-up, with an optional open-label extension. Approximately 180 participants will be enrolled across clinical sites in the United States, Canada, and Europe. Topline results for the primary efficacy endpoint are anticipated in the third quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL9rnNNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2536681655","title":"H.C. Wainwright Remains a Hold on Zura Bio (ZURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536681655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536681655?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:16","pubTimestamp":1747657000,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Hold rating on Zura Bio (ZURA – Research Report) today and set a price target of $3.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-hold-on-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-hold-on-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2535770074","title":"Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Zura Bio (ZURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535770074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535770074?lang=en_us&edition=fundamental","pubTime":"2025-05-13 22:20","pubTimestamp":1747146010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Relay Therapeutics (RLAY – Research Report) and Zura...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-relay-therapeutics-rlay-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-relay-therapeutics-rlay-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","BK4137","RLAY","ZURA","BK4563"],"gpt_icon":0},{"id":"2534439300","title":"Zura Bio Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2534439300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534439300?lang=en_us&edition=fundamental","pubTime":"2025-05-09 22:56","pubTimestamp":1746802590,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd reports results for the quarter ended March 31 - Earnings SummaryZura Bio Ltd ZURA.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter ended March 31, lower than t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2534482766","title":"Oppenheimer Sticks to Their Buy Rating for Zura Bio (ZURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534482766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534482766?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:18","pubTimestamp":1746796723,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Jeff Jones maintained a Buy rating on Zura Bio (ZURA – Research Report) today and set a price target of $17.00. The company’s s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-zura-bio-zura-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-zura-bio-zura-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","OPY"],"gpt_icon":0},{"id":"2534482753","title":"Zura Bio price target lowered to $17 from $19 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2534482753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534482753?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:16","pubTimestamp":1746796583,"startTime":"0","endTime":"0","summary":"Oppenheimer lowered the firm’s price target on Zura Bio (ZURA) to $17 from $19 and keeps an Outperform rating on the shares. The firm notes Zura re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zura-bio-price-target-lowered-to-17-from-19-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zura-bio-price-target-lowered-to-17-from-19-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","ZURA"],"gpt_icon":0},{"id":"2533907497","title":"Zura Bio Q1 EPS $(0.19) Misses $(0.15) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533907497","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533907497?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:40","pubTimestamp":1746700819,"startTime":"0","endTime":"0","summary":"Zura Bio Q1 EPS $(0.19) Misses $(0.15) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45280202/zura-bio-q1-eps-0-19-misses-0-15-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2533429500","title":"Zura Bio Ltd  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533429500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533429500?lang=en_us&edition=fundamental","pubTime":"2025-05-06 18:33","pubTimestamp":1746527592,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd  expected to post a loss of15cents a share - Earnings Preview Zura Bio Ltd ZURA.OQ ZURA.O is expected to show no change in quarterly revenue when it reports  results on May 8 (estimated) ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL8N3RE0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZURA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"ZURA","fiscalQuarterEnding":"2025/03","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-03-25","symbol":"ZURA","fiscalQuarterEnding":"2024/12","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2024-11-07","symbol":"ZURA","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-08-13","symbol":"ZURA","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-05-09","symbol":"ZURA","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1730779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZURA","date":"2025-08-01","current":-1.394972,"percent":0.876271,"low":-19.645373,"twenty":-6.9051,"median":-3.454611,"eighty":-1.787565,"high":128.323671,"avg":-0.965522,"sd":19.015623,"marketCap":86624997},"quantilePoints":[{"date":"2023-03-17","current":6.722013,"twenty":3.077283,"median":4.444057,"eighty":5.810831,"marketCap":55244013},{"date":"2023-03-24","current":95.732999,"twenty":10.089418,"median":26.552728,"eighty":97.24286,"marketCap":786769586},{"date":"2023-03-31","current":115.825116,"twenty":24.157776,"median":96.676662,"eighty":121.414532,"marketCap":411078048},{"date":"2023-04-06","current":88.654345,"twenty":26.552728,"median":98.493858,"eighty":115.825116,"marketCap":314645530},{"date":"2023-04-14","current":87.334622,"twenty":54.797542,"median":97.620325,"eighty":115.825116,"marketCap":309961665},{"date":"2023-04-21","current":-9.744092,"twenty":23.559038,"median":92.924037,"eighty":110.2357,"marketCap":273592829},{"date":"2023-04-28","current":-7.850225,"twenty":-7.693221,"median":87.334622,"eighty":108.0657,"marketCap":220417184},{"date":"2023-05-05","current":-5.625705,"twenty":-7.58528,"median":65.049697,"eighty":103.1713,"marketCap":157957503},{"date":"2023-05-12","current":-8.54785,"twenty":-7.58528,"median":23.559038,"eighty":100.454223,"marketCap":240004959},{"date":"2023-05-19","current":-6.028363,"twenty":-7.236336,"median":-1.370145,"eighty":99.367392,"marketCap":169263255},{"date":"2023-05-26","current":-6.110447,"twenty":-6.948723,"median":-5.106395,"eighty":97.620325,"marketCap":171568003},{"date":"2023-06-02","current":-7.079022,"twenty":-6.974783,"median":-5.279277,"eighty":96.110464,"marketCap":198763468},{"date":"2023-06-09","current":-7.871872,"twenty":-7.497414,"median":-5.756178,"eighty":93.610039,"marketCap":221024977},{"date":"2023-06-16","current":-12.462533,"twenty":-7.876403,"median":-5.936326,"eighty":92.830881,"marketCap":349920722},{"date":"2023-06-23","current":-18.356145,"twenty":-8.029209,"median":-6.09739,"eighty":90.300117,"marketCap":515400472},{"date":"2023-06-30","current":-12.800188,"twenty":-8.465056,"median":-6.110447,"eighty":88.126456,"marketCap":359401332},{"date":"2023-07-07","current":-10.897043,"twenty":-9.736242,"median":-6.32748,"eighty":86.946468,"marketCap":305965163},{"date":"2023-07-14","current":-10.375213,"twenty":-10.301543,"median":-6.449998,"eighty":83.375453,"marketCap":291313310},{"date":"2023-07-21","current":-10.144993,"twenty":-10.16955,"median":-6.948723,"eighty":71.20099,"marketCap":284849257},{"date":"2023-07-28","current":-10.083602,"twenty":-10.362935,"median":-7.293596,"eighty":49.148579,"marketCap":283125510},{"date":"2023-08-04","current":-9.776643,"twenty":-10.464231,"median":-7.58528,"eighty":25.95399,"marketCap":274506773},{"date":"2023-08-11","current":-10.449013,"twenty":-10.439697,"median":-7.861048,"eighty":20.191633,"marketCap":293385452},{"date":"2023-08-18","current":-10.480065,"twenty":-10.545755,"median":-7.939831,"eighty":5.810831,"marketCap":294257326},{"date":"2023-08-25","current":-10.480065,"twenty":-10.559049,"median":-8.143707,"eighty":0.751603,"marketCap":294257326},{"date":"2023-09-01","current":-10.681903,"twenty":-10.607717,"median":-8.54785,"eighty":-4.921342,"marketCap":299924504},{"date":"2023-09-08","current":-4.570525,"twenty":-10.559388,"median":-8.166359,"eighty":-4.757501,"marketCap":287718274},{"date":"2023-09-15","current":-4.764426,"twenty":-10.559388,"median":-7.953905,"eighty":-4.66055,"marketCap":299924504},{"date":"2023-09-22","current":-4.258898,"twenty":-10.557695,"median":-7.871872,"eighty":-4.251973,"marketCap":268101119},{"date":"2023-09-29","current":-4.473574,"twenty":-10.542169,"median":-7.639251,"eighty":-4.258898,"marketCap":281615159},{"date":"2023-10-06","current":-4.757501,"twenty":-10.497996,"median":-7.350856,"eighty":-4.283136,"marketCap":299488567},{"date":"2023-10-13","current":-4.383549,"twenty":-10.495591,"median":-7.013872,"eighty":-4.383549,"marketCap":275947981},{"date":"2023-10-20","current":-3.573319,"twenty":-10.495591,"median":-6.455254,"eighty":-4.196573,"marketCap":224943378},{"date":"2023-10-27","current":-3.573319,"twenty":-10.490414,"median":-6.444741,"eighty":-4.161948,"marketCap":224943378},{"date":"2023-11-03","current":-3.414044,"twenty":-10.481615,"median":-6.238867,"eighty":-3.923726,"marketCap":214916832},{"date":"2023-11-10","current":-2.956991,"twenty":-10.480065,"median":-6.108894,"eighty":-3.419584,"marketCap":186145005},{"date":"2023-11-17","current":-2.648491,"twenty":-10.467644,"median":-5.982344,"eighty":-3.254768,"marketCap":185709068},{"date":"2023-11-24","current":-2.791485,"twenty":-10.449013,"median":-5.807949,"eighty":-3.105187,"marketCap":195735614},{"date":"2023-12-01","current":-3.015301,"twenty":-10.439697,"median":-5.625705,"eighty":-2.958376,"marketCap":211429338},{"date":"2023-12-08","current":-2.486846,"twenty":-10.40006,"median":-5.130482,"eighty":-2.892202,"marketCap":174374712},{"date":"2023-12-15","current":-2.611189,"twenty":-10.387491,"median":-4.906391,"eighty":-2.779051,"marketCap":183093447},{"date":"2023-12-22","current":-3.183163,"twenty":-10.362935,"median":-4.840601,"eighty":-2.781538,"marketCap":223199631},{"date":"2023-12-29","current":-2.984215,"twenty":-10.326099,"median":-4.826751,"eighty":-2.788998,"marketCap":209249654},{"date":"2024-01-05","current":-2.517932,"twenty":-10.262321,"median":-4.816363,"eighty":-2.775321,"marketCap":176554395},{"date":"2024-01-12","current":-2.443326,"twenty":-10.181318,"median":-4.764426,"eighty":-2.706932,"marketCap":171323154},{"date":"2024-01-19","current":-2.505498,"twenty":-10.172619,"median":-4.757501,"eighty":-2.649734,"marketCap":175682522},{"date":"2024-01-26","current":-2.238162,"twenty":-10.157271,"median":-4.695176,"eighty":-2.617406,"marketCap":156937240},{"date":"2024-02-02","current":-1.933523,"twenty":-10.132715,"median":-4.639775,"eighty":-2.529123,"marketCap":135576338},{"date":"2024-02-09","current":-2.437109,"twenty":-10.071324,"median":-4.573987,"eighty":-2.500524,"marketCap":170887217},{"date":"2024-02-16","current":-2.493063,"twenty":-10.01914,"median":-4.570525,"eighty":-2.486846,"marketCap":174810648},{"date":"2024-02-23","current":-2.275464,"twenty":-10.006862,"median":-4.432024,"eighty":-2.486846,"marketCap":159552861},{"date":"2024-03-01","current":-2.287899,"twenty":-9.776643,"median":-4.271017,"eighty":-2.449544,"marketCap":160424735},{"date":"2024-03-08","current":-2.001911,"twenty":-9.745947,"median":-4.196573,"eighty":-2.424675,"marketCap":140371643},{"date":"2024-03-15","current":-1.970826,"twenty":-9.744092,"median":-4.127323,"eighty":-2.35007,"marketCap":138191959},{"date":"2024-03-22","current":-1.796746,"twenty":-9.744092,"median":-3.981897,"eighty":-2.287899,"marketCap":125985729},{"date":"2024-03-28","current":-1.675569,"twenty":-9.733298,"median":-3.573319,"eighty":-2.275464,"marketCap":101137332},{"date":"2024-04-05","current":-2.094461,"twenty":-9.709993,"median":-3.420969,"eighty":-2.199615,"marketCap":126421666},{"date":"2024-04-12","current":-2.072794,"twenty":-9.700891,"median":-3.379418,"eighty":-2.090128,"marketCap":125113855},{"date":"2024-04-19","current":-2.665021,"twenty":-9.687625,"median":-3.254768,"eighty":-2.111795,"marketCap":160860671},{"date":"2024-04-26","current":-3.737907,"twenty":-9.574049,"median":-3.270203,"eighty":-2.116128,"marketCap":225620043},{"date":"2024-05-03","current":-4.502009,"twenty":-9.49731,"median":-3.407119,"eighty":-2.159044,"marketCap":271741268},{"date":"2024-05-10","current":-4.89959,"twenty":-8.765356,"median":-3.41781,"eighty":-2.190413,"marketCap":286699503},{"date":"2024-05-17","current":-6.390769,"twenty":-8.555367,"median":-3.573319,"eighty":-2.204775,"marketCap":373955874},{"date":"2024-05-24","current":-6.007323,"twenty":-8.382261,"median":-3.737907,"eighty":-2.231945,"marketCap":351518521},{"date":"2024-05-31","current":-5.591923,"twenty":-8.236161,"median":-3.981897,"eighty":-2.251609,"marketCap":327211389},{"date":"2024-06-07","current":-4.271164,"twenty":-8.139176,"median":-4.127323,"eighty":-2.264907,"marketCap":249927175},{"date":"2024-06-14","current":-4.015533,"twenty":-8.029209,"median":-4.079441,"eighty":-2.268667,"marketCap":234968940},{"date":"2024-06-21","current":-3.642739,"twenty":-7.95672,"median":-4.015533,"eighty":-2.271734,"marketCap":213154848},{"date":"2024-06-28","current":-3.727949,"twenty":-7.921709,"median":-3.977412,"eighty":-2.275464,"marketCap":218140926},{"date":"2024-07-05","current":-3.727949,"twenty":-7.889994,"median":-3.928937,"eighty":-2.276707,"marketCap":218140926},{"date":"2024-07-12","current":-4.041687,"twenty":-7.867543,"median":-3.951626,"eighty":-2.282925,"marketCap":236499340},{"date":"2024-07-19","current":-3.802019,"twenty":-7.818824,"median":-3.919672,"eighty":-2.287899,"marketCap":222475120},{"date":"2024-07-26","current":-4.23778,"twenty":-7.671633,"median":-3.972928,"eighty":-2.290386,"marketCap":247973702},{"date":"2024-08-02","current":-3.965429,"twenty":-7.563313,"median":-3.977412,"eighty":-2.30282,"marketCap":232037088},{"date":"2024-08-09","current":-3.693078,"twenty":-7.450529,"median":-3.972928,"eighty":-2.317741,"marketCap":216100475},{"date":"2024-08-16","current":-6.331005,"twenty":-7.327952,"median":-3.982738,"eighty":-2.340122,"marketCap":220439248},{"date":"2024-08-23","current":-6.480637,"twenty":-7.204873,"median":-4.015533,"eighty":-2.355044,"marketCap":225649304},{"date":"2024-08-30","current":-7.497208,"twenty":-7.492856,"median":-4.025346,"eighty":-2.376181,"marketCap":261045273},{"date":"2024-09-06","current":-6.630361,"twenty":-7.475447,"median":-4.052581,"eighty":-2.381155,"marketCap":230862542},{"date":"2024-09-13","current":-6.776887,"twenty":-7.472893,"median":-4.085772,"eighty":-2.387372,"marketCap":235964443},{"date":"2024-09-20","current":-8.132265,"twenty":-7.497208,"median":-4.101605,"eighty":-2.390574,"marketCap":283157332},{"date":"2024-09-27","current":-7.454576,"twenty":-7.497208,"median":-4.139734,"eighty":-2.424675,"marketCap":259560888},{"date":"2024-10-04","current":-8.022369,"twenty":-7.564472,"median":-4.172629,"eighty":-2.426686,"marketCap":279330882},{"date":"2024-10-11","current":-7.43626,"twenty":-7.58528,"median":-4.207257,"eighty":-2.437109,"marketCap":258923146},{"date":"2024-10-18","current":-9.011429,"twenty":-7.619419,"median":-4.255435,"eighty":-2.443326,"marketCap":313768936},{"date":"2024-10-25","current":-8.681742,"twenty":-7.710999,"median":-4.283136,"eighty":-2.443326,"marketCap":302289584},{"date":"2024-11-01","current":-8.022369,"twenty":-7.871872,"median":-4.341273,"eighty":-2.449544,"marketCap":279330882},{"date":"2024-11-08","current":-6.328847,"twenty":-7.875842,"median":-4.409078,"eighty":-2.461978,"marketCap":299044367},{"date":"2024-11-15","current":-4.366628,"twenty":-7.871872,"median":-4.447456,"eighty":-2.468195,"marketCap":206327554},{"date":"2024-11-22","current":-3.772435,"twenty":-7.850225,"median":-4.409078,"eighty":-2.474412,"marketCap":178251336},{"date":"2024-11-29","current":-4.214625,"twenty":-7.812108,"median":-4.379403,"eighty":-2.484359,"marketCap":199145266},{"date":"2024-12-06","current":-3.979712,"twenty":-7.747073,"median":-4.327977,"eighty":-2.486846,"marketCap":188045366},{"date":"2024-12-13","current":-3.150605,"twenty":-7.715439,"median":-4.283136,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-20","current":-3.150605,"twenty":-7.696777,"median":-4.255435,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-27","current":-3.454611,"twenty":-7.692898,"median":-4.233112,"eighty":-2.486846,"marketCap":163233825},{"date":"2025-01-03","current":-3.565159,"twenty":-7.679844,"median":-4.210941,"eighty":-2.489333,"marketCap":168457307},{"date":"2025-01-10","current":-2.984784,"twenty":-7.652352,"median":-4.189941,"eighty":-2.494306,"marketCap":141034024},{"date":"2025-01-17","current":-2.445865,"twenty":-7.615756,"median":-4.161948,"eighty":-2.488469,"marketCap":115569548},{"date":"2025-01-24","current":-2.376772,"twenty":-7.601103,"median":-4.145533,"eighty":-2.486846,"marketCap":112304871},{"date":"2025-01-31","current":-2.597867,"twenty":-7.587973,"median":-4.117946,"eighty":-2.474412,"marketCap":122751836},{"date":"2025-02-07","current":-2.293862,"twenty":-7.58528,"median":-4.092697,"eighty":-2.461978,"marketCap":108387259},{"date":"2025-02-14","current":-2.141859,"twenty":-7.564472,"median":-4.071459,"eighty":-2.445865,"marketCap":101204971},{"date":"2025-02-21","current":-1.934582,"twenty":-7.535166,"median":-4.045246,"eighty":-2.436096,"marketCap":91410942},{"date":"2025-02-28","current":-1.879308,"twenty":-7.503334,"median":-4.019899,"eighty":-2.390588,"marketCap":88799200},{"date":"2025-03-07","current":-1.741124,"twenty":-7.479799,"median":-4.012269,"eighty":-2.376772,"marketCap":82269847},{"date":"2025-03-14","current":-1.768761,"twenty":-7.473404,"median":-3.98358,"eighty":-2.360377,"marketCap":83575718},{"date":"2025-03-21","current":-1.920764,"twenty":-7.458239,"median":-3.97632,"eighty":-2.299039,"marketCap":90758006},{"date":"2025-03-28","current":-1.650561,"twenty":-7.439923,"median":-3.965429,"eighty":-2.286655,"marketCap":86494372},{"date":"2025-04-04","current":-1.343935,"twenty":-7.43626,"median":-3.888445,"eighty":-2.268957,"marketCap":70426247},{"date":"2025-04-11","current":-1.578798,"twenty":-7.43626,"median":-3.869164,"eighty":-2.22123,"marketCap":82733747},{"date":"2025-04-17","current":-1.604894,"twenty":-7.385018,"median":-3.866416,"eighty":-2.158607,"marketCap":84101247},{"date":"2025-04-25","current":-1.787565,"twenty":-7.336161,"median":-3.851042,"eighty":-2.091311,"marketCap":93673747},{"date":"2025-05-02","current":-1.918044,"twenty":-7.319952,"median":-3.834462,"eighty":-2.07178,"marketCap":100511247},{"date":"2025-05-09","current":-1.205655,"twenty":-7.300111,"median":-3.807466,"eighty":-2.049161,"marketCap":74868747},{"date":"2025-05-16","current":-1.106014,"twenty":-7.278743,"median":-3.786254,"eighty":-2.016502,"marketCap":68681247},{"date":"2025-05-23","current":-1.036265,"twenty":-7.271417,"median":-3.738253,"eighty":-2.007994,"marketCap":64349997},{"date":"2025-05-30","current":-1.016337,"twenty":-7.257385,"median":-3.729465,"eighty":-1.994142,"marketCap":63112497},{"date":"2025-06-06","current":-1.14587,"twenty":-7.235716,"median":-3.693078,"eighty":-1.973826,"marketCap":71156247},{"date":"2025-06-13","current":-1.215619,"twenty":-7.20548,"median":-3.669367,"eighty":-1.948401,"marketCap":75487497},{"date":"2025-06-20","current":-1.106014,"twenty":-7.150532,"median":-3.621436,"eighty":-1.94414,"marketCap":68681247},{"date":"2025-06-27","current":-1.14587,"twenty":-7.101064,"median":-3.600133,"eighty":-1.923316,"marketCap":71156247},{"date":"2025-07-03","current":-1.125942,"twenty":-7.079022,"median":-3.589482,"eighty":-1.914872,"marketCap":69918747},{"date":"2025-07-11","current":-1.385008,"twenty":-7.069942,"median":-3.569239,"eighty":-1.8789,"marketCap":86006247},{"date":"2025-07-18","current":-1.952961,"twenty":-7.051626,"median":-3.482969,"eighty":-1.86549,"marketCap":121274996},{"date":"2025-07-25","current":-1.673967,"twenty":-6.948723,"median":-3.46152,"eighty":-1.837853,"marketCap":103949996},{"date":"2025-08-01","current":-1.394972,"twenty":-6.9051,"median":-3.454611,"eighty":-1.787565,"marketCap":86624997}],"updateTime":1754224745513}}}